SG Americas Securities
GPCR icon

SG Americas Securities’s Structure Therapeutics GPCR Stock Holding History

SG Americas Securities’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Sell
2,427
-222
-8% -$9.82K ﹤0.01% 2990
2026
Q1 		$128K Sell
2,649
-7,498
-74% -$513K ﹤0.01% 2834
2025
Q4 		$706K Sell
10,147
-29,553
-74% -$1.21M ﹤0.01% 2289
2025
Q3 		$1.11M Buy
39,700
+20,461
+106% +$408K ﹤0.01% 1362
2025
Q2 		$399K Buy
+19,239
New +$423K ﹤0.01% 1813
2025
Q1 		– Sell
-5,445
Closed -$148K – 3578
2024
Q4 		$148K Sell
5,445
-2,911
-35% -$103K ﹤0.01% 2415
2024
Q3 		$367K Buy
+8,356
New +$323K ﹤0.01% 1961

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SG Americas Securities's GPCR Position: Q2 2026 in Review

SG Americas Securities reduced its Structure Therapeutics (GPCR) stake by 8.4% in Q2 2026, selling an estimated $9.82K and leaving 2,427 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

SG Americas Securities first reported a position in GPCR in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q3 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • SG Americas Securities held 2,427 shares of Structure Therapeutics worth $130K as of Q2 2026.
  • SG Americas Securities sold 222 Structure Therapeutics shares in Q2 2026, an estimated $9.82K.
  • Structure Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2990 holding.
  • SG Americas Securities first reported a position in Structure Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • SG Americas Securities's Structure Therapeutics position peaked at $1.11M in Q3 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.